Katharine was Chief Medical Officer at Agilent Technologies, and Director at Arena Pharmaceuticals. Katharine Knobil joined Marker Therapeutics in 2024.
Katharine Knobil is currently
Create your alert
to follow the career of Katharine Knobil.
Katharine Knobil has a Doctor of Medicine from The University of Texas Southwestern Medical School and a Residence in Internal Medicine from University of Michigan Medical School.
Do you need to know more about Katharine Knobil? More results.
Report an error
Update the org chart details of Katharine Knobil.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.